Published in Cancer Weekly, June 12th, 2007
The system, called C-MAP, is designed to be a faster, less expensive and more accurate way to screen for cervical cancer than Pap tests and other current screening approaches. It examines the behavior of groups of cells within discrete areas of the cervix, allowing lesions to be effectively analyzed in situ. Because results are...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.